Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 12, 2014, Pages 2241-2247

  Faria Ramos, I ^a   Neves Maia, J ^a   Ricardo, E ^a   Santos Antunes, J ^a,b   Silva, A T ^a   Costa de Oliveira, S ^a   Canton E ^c   Rodrigues, A G ^a,b   Pina Vaz, C ^a,b  

^a University of Porto   (Portugal)

^b Centro Hospitalar Universitário de São João   (Portugal)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECHINOCANDIN; PYRROLE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DEATH; DESCRIPTIVE RESEARCH; FEMALE; FUNGEMIA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYCOSIS; OBSERVATIONAL STUDY; PORTUGAL; PORTUGUESE (CITIZEN); PRACTICE GUIDELINE; PUBLIC HOSPITAL; QUESTIONNAIRE; SEX DIFFERENCE; SPECIES DISTRIBUTION; YOUNG ADULT; ADOLESCENT; CANDIDA; CANDIDEMIA; CHILD; CLINICAL TRIAL; DRUG EFFECTS; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PORTUGAL; YOUNG ADULT;

EID: 84911980763     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2194-8     Document Type: Article

References (29)

1. Arendrup MC (2010) Epidemiology of invasive candidiasis. Curr Opin Crit Care 16:445–452
2. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA; Global Antifungal Surveillance Group (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48:1366–1377
3. Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, Pintado V, Cobo J, Fresco G, Meije Y, Ros L, Alvarez ME, Luengo J, Agundez M, Belso A, Sánchez-Sousa A, Loza E, Moreno S (2012) Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect 65:64–70
4. Yapar N (2014) Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 10:95–105
5. Playford EG, Nimmo GR, Tilse M, Sorrell TC (2010) Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999–2008. J Hosp Infect 76:46–51
6. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard—Third edition. CLSI document M27-A3. CLSI, Wayne, PA
7. Clinical and Laboratory Standards Institute (CLSI) (2012) Reference method for broth dilution antifungal susceptibility testing of yeasts; Fourth informational supplement. CLSI document M27-S4. CLSI, Wayne, PA
8. Rodríguez-Tudela JL, Arendrup MC, Cuenca-Estrella M, Donnelly JP, Lass-Flörl C (2010) EUCAST breakpoints for antifungals. Drug News Perspect 23:93–97
9. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D; CLSI Subcommittee for Antifungal Susceptibility Testing (2010) Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 13:180–195
10. Romeo O, Scordino F, Pernice I, Lo Passo C, Criseo G (2009) A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J Microbiol Methods 79(1):117–120
11. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC (2005) Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 43:284–292
12. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J (2013) Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 57:5836–5842
13. Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, Fothergill A, Fuller J, Ghannoum M, Jones RN, Lockhart SR, Martin-Mazuelos E, Melhem MS, Ostrosky-Zeichner L, Pappas P, Pelaez T, Peman J, Rex J, Szeszs MW (2012) Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol 50:2040–2046
14. Tortorano AM, Prigitano A, Lazzarini C, Passera M, Deiana ML, Cavinato S, De Luca C, Grancini A, Lo Cascio G, Ossi C, Sala E, Montagna MT (2013) A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection 41:655–662
15. Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group (2012) Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 67:1181–1187
16. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J; Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816–2823
17. Costa-de-Oliveira S, Pina-Vaz C, Mendonça D, Gonçalves Rodrigues A (2008) A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis 27:365–374
18. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M (2013) Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 51(3):841–848
19. Das I, Nightingale P, Patel M, Jumaa P (2011) Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15:e759–e763
20. Wu Z, Liu Y, Feng X, Liu Y, Wang S, Zhu X, Chen Q, Pan S (2014) Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China. Int J Infect Dis 22:4–8
21. Quindós G (2014) Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 31:42–48
22. Chalmers C, Gaur S, Chew J, Wright T, Kumar A, Mathur S, Wan WY, Gould IM, Leanord A, Bal AM (2011) Epidemiology and management of candidaemia—a retrospective, multicentre study in five hospitals in the UK. Mycoses 54:e795–e800
23. Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Røder BL, Schønheyder HC (2013) Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect 19:E343–E353
24. Ericsson J, Chryssanthou E, Klingspor L, Johansson AG, Ljungman P, Svensson E, Sjölin J (2013) Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect 19:E218–E221
25. Bonfietti LX, Szeszs MW, Chang MR, Martins MA, Pukinskas SR, Nunes MO, Pereira GH, Paniago AM, Purisco SU, Melhem MS (2012) Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital. Mycopathologia 174:389–396
26. Tosun I, Akyuz Z, Guler NC, Gulmez D, Bayramoglu G, Kaklikkaya N, Arikan-Akdagli S, Aydin F (2013) Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples. Med Mycol 51:483–492
27. Esposto MC, Prigitano A, Romeo O, Criseo G, Trovato L, Tullio V, Fadda ME, Tortorano AM; FIMUA Working Group (2013) Looking for Candida nivariensis and C. bracarensis among a large Italian collection of C. glabrata isolates: results of the FIMUA working group. Mycoses 56:394–396
28. Pfaller MA, Espinel-Ingroff A, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ (2011) Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values. J Clin Microbiol 49:845–850
29. Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN (2014) Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn Microbiol Infect Dis 79:198–204